223 related articles for article (PubMed ID: 31756675)
1. Elevated levels of IL-6 and IGFBP-1 predict low serum IGF-1 levels during continuous infusion of rhIGF-1/rhIGFBP-3 in extremely preterm infants.
Klevebro S; Hellgren G; Hansen-Pupp I; Wackernagel D; Hallberg B; Borg J; Pivodic A; Smith L; Ley D; Hellström A
Growth Horm IGF Res; 2020 Feb; 50():1-8. PubMed ID: 31756675
[TBL] [Abstract][Full Text] [Related]
2. Continuous longitudinal infusion of rhIGF-1/rhIGFBP-3 in extremely preterm infants: Evaluation of feasibility in a phase II study.
Hansen-Pupp I; Hellström A; Hamdani M; Tocoian A; Kreher NC; Ley D; Hallberg B
Growth Horm IGF Res; 2017 Oct; 36():44-51. PubMed ID: 28934640
[TBL] [Abstract][Full Text] [Related]
3. rhIGF-1/rhIGFBP-3 in Preterm Infants: A Phase 2 Randomized Controlled Trial.
Ley D; Hallberg B; Hansen-Pupp I; Dani C; Ramenghi LA; Marlow N; Beardsall K; Bhatti F; Dunger D; Higginson JD; Mahaveer A; Mezu-Ndubuisi OJ; Reynolds P; Giannantonio C; van Weissenbruch M; Barton N; Tocoian A; Hamdani M; Jochim E; Mangili A; Chung JK; Turner MA; Smith LEH; Hellström A;
J Pediatr; 2019 Mar; 206():56-65.e8. PubMed ID: 30471715
[TBL] [Abstract][Full Text] [Related]
4. Longitudinal infusion of a complex of insulin-like growth factor-I and IGF-binding protein-3 in five preterm infants: pharmacokinetics and short-term safety.
Ley D; Hansen-Pupp I; Niklasson A; Domellöf M; Friberg LE; Borg J; Löfqvist C; Hellgren G; Smith LE; Hård AL; Hellström A
Pediatr Res; 2013 Jan; 73(1):68-74. PubMed ID: 23095978
[TBL] [Abstract][Full Text] [Related]
5. Development and verification of a pharmacokinetic model to optimize physiologic replacement of rhIGF-1/rhIGFBP-3 in preterm infants.
Chung JK; Hallberg B; Hansen-Pupp I; Graham MA; Fetterly G; Sharma J; Tocoian A; Kreher NC; Barton N; Hellström A; Ley D
Pediatr Res; 2017 Mar; 81(3):504-510. PubMed ID: 27870826
[TBL] [Abstract][Full Text] [Related]
6. Pilot dose-ranging of rhIGF-1/rhIGFBP-3 in a preterm lamb model of evolving bronchopulmonary dysplasia.
Albertine KH; Dahl MJ; Rebentisch A; Dawson E; Nabi A; Bowen S; Miers C; Wang Z; Yang H; Yu B; Null DM; Keefe D; Chung JK; Zhou Z; Barton N; Carey G; Ward R
Pediatr Res; 2023 May; 93(6):1528-1538. PubMed ID: 36030318
[TBL] [Abstract][Full Text] [Related]
7. Safety aspects of longitudinal administration of IGF-I/IGFBP-3 complex in neonatal mice.
Hellgren G; Han W; Wang X; Löfqvist C; Hagberg H; Mallard C; Hellström A
Growth Horm IGF Res; 2011 Aug; 21(4):205-11. PubMed ID: 21696987
[TBL] [Abstract][Full Text] [Related]
8. A pharmacokinetic and dosing study of intravenous insulin-like growth factor-I and IGF-binding protein-3 complex to preterm infants.
Löfqvist C; Niklasson A; Engström E; Friberg LE; Camacho-Hübner C; Ley D; Borg J; Smith LE; Hellström A
Pediatr Res; 2009 May; 65(5):574-9. PubMed ID: 19190540
[TBL] [Abstract][Full Text] [Related]
9. Mecasermin rinfabate: insulin-like growth factor-I/insulin-like growth factor binding protein-3, mecaserimin rinfibate, rhIGF-I/rhIGFBP-3.
Drugs R D; 2005; 6(2):120-7. PubMed ID: 15777106
[TBL] [Abstract][Full Text] [Related]
10. Insulin-Like Growth Factor 1 in the Preterm Rabbit Pup: Characterization of Cerebrovascular Maturation following Administration of Recombinant Human Insulin-Like Growth Factor 1/Insulin-Like Growth Factor 1-Binding Protein 3.
Gram M; Ekström C; Holmqvist B; Carey G; Wang X; Vallius S; Hellström W; Ortenlöf N; Agyemang AA; Smith LEH; Hellström A; Mangili A; Barton N; Ley D
Dev Neurosci; 2021; 43(5):281-295. PubMed ID: 34218224
[TBL] [Abstract][Full Text] [Related]
11. Insulin-like growth factor-I treatment in primary growth hormone insensitivity: effect of recombinant human IGF-I (rhIGF-I) and rhIGF-I/rhIGF-binding protein-3 complex.
Tonella P; Flück CE; Mullis PE
Horm Res Paediatr; 2010; 73(2):140-7. PubMed ID: 20190552
[TBL] [Abstract][Full Text] [Related]
12. Effects of combined recombinant insulin-like growth factor (IGF)-I and IGF binding protein-3 in type 2 diabetic patients on glycemic control and distribution of IGF-I and IGF-II among serum binding protein complexes.
Clemmons DR; Sleevi M; Allan G; Sommer A
J Clin Endocrinol Metab; 2007 Jul; 92(7):2652-8. PubMed ID: 17426090
[TBL] [Abstract][Full Text] [Related]
13. Recombinant human insulin-like growth factor (IGF)-binding protein-1 inhibits somatic growth stimulated by IGF-I and growth hormone in hypophysectomized rats.
Cox GN; McDermott MJ; Merkel E; Stroh CA; Ko SC; Squires CH; Gleason TM; Russell D
Endocrinology; 1994 Nov; 135(5):1913-20. PubMed ID: 7525258
[TBL] [Abstract][Full Text] [Related]
14. Biochemical markers of recombinant human insulin-like growth factor-I (rhIGF-I)/rhIGF binding protein-3 (rhIGFBP-3) misuse in athletes.
Guha N; Erotokritou-Mulligan I; Nevitt SP; Francis M; Bartlett C; Cowan DA; Bassett EE; Sönksen PH; Holt RI
Drug Test Anal; 2013; 5(11-12):843-9. PubMed ID: 24173773
[TBL] [Abstract][Full Text] [Related]
15. The IGF system and longitudinal growth in preterm infants in relation to gestational age, birth weight and gender.
Hellström A; Sigurdsson J; Löfqvist C; Hellgren G; Kistner A
Growth Horm IGF Res; 2020 Apr; 51():46-57. PubMed ID: 32114373
[TBL] [Abstract][Full Text] [Related]
16. Assessment of compatibility of rhIGF-1/rhIGFBP-3 with neonatal intravenous medications.
Salamat-Miller N; Turner MA; Bandekar A; Dixit N; Jochim E; Mangum B; McPherson C; Tenjarla S; Singh S; Hwang YS; Barton N
World J Pediatr; 2023 Jan; 19(1):58-67. PubMed ID: 36344872
[TBL] [Abstract][Full Text] [Related]
17. Pharmacokinetic studies of recombinant human insulin-like growth factor I (rhIGF-I)/rhIGF-binding protein-3 complex administered to patients with growth hormone insensitivity syndrome.
Camacho-Hübner C; Rose S; Preece MA; Sleevi M; Storr HL; Miraki-Moud F; Minuto F; Frystyk J; Rogol A; Allan G; Sommer A; Savage MO
J Clin Endocrinol Metab; 2006 Apr; 91(4):1246-53. PubMed ID: 16403822
[TBL] [Abstract][Full Text] [Related]
18. Randomized Control Trial of Postnatal rhIGF-1/rhIGFBP-3 Replacement in Preterm Infants:
Horsch S; Parodi A; Hallberg B; Malova M; Björkman-Burtscher IM; Hansen-Pupp I; Marlow N; Beardsall K; Dunger D; van Weissenbruch M; Smith LEH; Hamdani M; Mangili A; Barton N; Ramenghi LA; Hellström A; Ley D;
Front Pediatr; 2020; 8():517207. PubMed ID: 33163463
[No Abstract] [Full Text] [Related]
19. Novel markers to detect recombinant human insulin-like growth factor-I (rhIGF-I)/rhIGF binding protein-3 (rhIGFBP-3) misuse in athletes.
Holt RI; Guha N; Böhning W; Bartlett C; Cowan DA; Sönksen PH; Böhning D
Drug Test Anal; 2017 Jan; 9(1):30-37. PubMed ID: 26888146
[TBL] [Abstract][Full Text] [Related]
20. rhIGF-I/IGFBP-3 complex, but not free rhIGF-I, supports muscle protein biosynthesis in rats during semistarvation.
Svanberg E; Ohlsson C; Kimball SR; Lundholm K
Eur J Clin Invest; 2000 May; 30(5):438-46. PubMed ID: 10809904
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
